Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients

Guido Torzilli, Masatoshi Makuuchi, Alessandro Ferrero, Tadatoshi Takayama, Hideki Abe, Kazuto Inoue, Kazuhiko Nakahara

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background/Aims: The diagnostic accuracy of tumor markers for differentiating focal liver lesions is not yet defined. Therefore, we carried out a retrospective analysis to address this issue. Methodology: We retrospectively evaluated 192 consecutive patients with 289 focal liver lesions. The serum levels of AFP, PIVKA II, CEA, and CA19-9 were determined in 119 patients, while at least one of these values was lacking in the others. All patients underwent liver resection: 136 patients had hepatocellular carcinoma, 39 metastases, 9 cholangiocarcinoma, 1 mixed hepatocellular carcinoma-cholangiocarcinoma, and 7 benign lesions. Results: At least one of the tumor markers examined was elevated in 169 of the 185 patients with proven malignancy. In 92 cases, the elevation was marked. The mean levels of each tumor marker were significantly different among patients grouped according to the tumor type. ROC curves showed that 10ng/mL was the optimal cut-off level for AFP and hepatocellular carcinoma, and for CEA and colorectal liver metastases. CEA and CA 19-9 showed specific patterns of elevation in liver metastases and cholangiocarcinoma. Conclusions: Common tumor markers for focal liver lesions were significantly linked to the type of the tumor. These findings suggest that their selective estimation may be useful for the preoperative diagnosis of focal liver lesions.

Original languageEnglish
Pages (from-to)740-745
Number of pages6
JournalHepato-Gastroenterology
Volume49
Issue number45
Publication statusPublished - 2002

Fingerprint

Tumor Biomarkers
Liver
Cholangiocarcinoma
Hepatocellular Carcinoma
Neoplasm Metastasis
Neoplasms
ROC Curve
Serum

Keywords

  • Cholangiocarcinoma
  • Diagnosis
  • Hepatocelular carcinoma
  • Liver Metastases
  • Liver tumors
  • Tumor markers

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Torzilli, G., Makuuchi, M., Ferrero, A., Takayama, T., Abe, H., Inoue, K., & Nakahara, K. (2002). Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. Hepato-Gastroenterology, 49(45), 740-745.

Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. / Torzilli, Guido; Makuuchi, Masatoshi; Ferrero, Alessandro; Takayama, Tadatoshi; Abe, Hideki; Inoue, Kazuto; Nakahara, Kazuhiko.

In: Hepato-Gastroenterology, Vol. 49, No. 45, 2002, p. 740-745.

Research output: Contribution to journalArticle

Torzilli, G, Makuuchi, M, Ferrero, A, Takayama, T, Abe, H, Inoue, K & Nakahara, K 2002, 'Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients', Hepato-Gastroenterology, vol. 49, no. 45, pp. 740-745.
Torzilli, Guido ; Makuuchi, Masatoshi ; Ferrero, Alessandro ; Takayama, Tadatoshi ; Abe, Hideki ; Inoue, Kazuto ; Nakahara, Kazuhiko. / Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. In: Hepato-Gastroenterology. 2002 ; Vol. 49, No. 45. pp. 740-745.
@article{f0a2366013d34da6ba2b1f8569135a28,
title = "Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients",
abstract = "Background/Aims: The diagnostic accuracy of tumor markers for differentiating focal liver lesions is not yet defined. Therefore, we carried out a retrospective analysis to address this issue. Methodology: We retrospectively evaluated 192 consecutive patients with 289 focal liver lesions. The serum levels of AFP, PIVKA II, CEA, and CA19-9 were determined in 119 patients, while at least one of these values was lacking in the others. All patients underwent liver resection: 136 patients had hepatocellular carcinoma, 39 metastases, 9 cholangiocarcinoma, 1 mixed hepatocellular carcinoma-cholangiocarcinoma, and 7 benign lesions. Results: At least one of the tumor markers examined was elevated in 169 of the 185 patients with proven malignancy. In 92 cases, the elevation was marked. The mean levels of each tumor marker were significantly different among patients grouped according to the tumor type. ROC curves showed that 10ng/mL was the optimal cut-off level for AFP and hepatocellular carcinoma, and for CEA and colorectal liver metastases. CEA and CA 19-9 showed specific patterns of elevation in liver metastases and cholangiocarcinoma. Conclusions: Common tumor markers for focal liver lesions were significantly linked to the type of the tumor. These findings suggest that their selective estimation may be useful for the preoperative diagnosis of focal liver lesions.",
keywords = "Cholangiocarcinoma, Diagnosis, Hepatocelular carcinoma, Liver Metastases, Liver tumors, Tumor markers",
author = "Guido Torzilli and Masatoshi Makuuchi and Alessandro Ferrero and Tadatoshi Takayama and Hideki Abe and Kazuto Inoue and Kazuhiko Nakahara",
year = "2002",
language = "English",
volume = "49",
pages = "740--745",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "45",

}

TY - JOUR

T1 - Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients

AU - Torzilli, Guido

AU - Makuuchi, Masatoshi

AU - Ferrero, Alessandro

AU - Takayama, Tadatoshi

AU - Abe, Hideki

AU - Inoue, Kazuto

AU - Nakahara, Kazuhiko

PY - 2002

Y1 - 2002

N2 - Background/Aims: The diagnostic accuracy of tumor markers for differentiating focal liver lesions is not yet defined. Therefore, we carried out a retrospective analysis to address this issue. Methodology: We retrospectively evaluated 192 consecutive patients with 289 focal liver lesions. The serum levels of AFP, PIVKA II, CEA, and CA19-9 were determined in 119 patients, while at least one of these values was lacking in the others. All patients underwent liver resection: 136 patients had hepatocellular carcinoma, 39 metastases, 9 cholangiocarcinoma, 1 mixed hepatocellular carcinoma-cholangiocarcinoma, and 7 benign lesions. Results: At least one of the tumor markers examined was elevated in 169 of the 185 patients with proven malignancy. In 92 cases, the elevation was marked. The mean levels of each tumor marker were significantly different among patients grouped according to the tumor type. ROC curves showed that 10ng/mL was the optimal cut-off level for AFP and hepatocellular carcinoma, and for CEA and colorectal liver metastases. CEA and CA 19-9 showed specific patterns of elevation in liver metastases and cholangiocarcinoma. Conclusions: Common tumor markers for focal liver lesions were significantly linked to the type of the tumor. These findings suggest that their selective estimation may be useful for the preoperative diagnosis of focal liver lesions.

AB - Background/Aims: The diagnostic accuracy of tumor markers for differentiating focal liver lesions is not yet defined. Therefore, we carried out a retrospective analysis to address this issue. Methodology: We retrospectively evaluated 192 consecutive patients with 289 focal liver lesions. The serum levels of AFP, PIVKA II, CEA, and CA19-9 were determined in 119 patients, while at least one of these values was lacking in the others. All patients underwent liver resection: 136 patients had hepatocellular carcinoma, 39 metastases, 9 cholangiocarcinoma, 1 mixed hepatocellular carcinoma-cholangiocarcinoma, and 7 benign lesions. Results: At least one of the tumor markers examined was elevated in 169 of the 185 patients with proven malignancy. In 92 cases, the elevation was marked. The mean levels of each tumor marker were significantly different among patients grouped according to the tumor type. ROC curves showed that 10ng/mL was the optimal cut-off level for AFP and hepatocellular carcinoma, and for CEA and colorectal liver metastases. CEA and CA 19-9 showed specific patterns of elevation in liver metastases and cholangiocarcinoma. Conclusions: Common tumor markers for focal liver lesions were significantly linked to the type of the tumor. These findings suggest that their selective estimation may be useful for the preoperative diagnosis of focal liver lesions.

KW - Cholangiocarcinoma

KW - Diagnosis

KW - Hepatocelular carcinoma

KW - Liver Metastases

KW - Liver tumors

KW - Tumor markers

UR - http://www.scopus.com/inward/record.url?scp=0036016722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036016722&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 740

EP - 745

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 45

ER -